Prognostic Nomograms Based on the Cirrhotic Severity Scoring for Preoperative Prediction of Long-Term Outcomes in Patients with HBV-Related Hepatocellular Carcinoma and Child-Pugh Grade A Liver Function
Table 2
Baseline characteristics.
Characteristics
Value
Age, years
Gender, (%)
Male
575 (90.4%)
Female
61 (9.6%)
Alanine aminotransferase, U/L
Albumin, g/L
Total bilirubin, μmol/L
ALBI grade
Grade 1
352 (55.3%)
Grade 2
284 (44.7%)
Prothrombin time, seconds
AFP, (%)
≤400 ng/mL
372 (58.5%)
>400 ng/mL
264 (41.5%)
Platelet count, 109/L
Portal vein diameter, cm
Splenic thickness, cm
Varicosity, (%)
No
554 (87.1%)
Mild
45 (7.1%)
Moderate
15 (2.4%)
Severe
22 (3.5%)
CSS, (%)
No/mild cirrhosis
363 (57.1%)
Moderate cirrhosis
175 (27.5%)
Severe cirrhosis
98 (15.4%)
Tumor size, cm
Tumor number, (%)
Single
525 (82.5%)
Multiple
111 (17.5%)
Macrovascular invasion, (%)
Absent
560 (88.1%)
Present
76 (11.9%)
BCLC stage, (%)
0/A
474 (74.5%)
B
82 (12.9%)
C
80 (12.6%)
CLIP score, (%)
0
293 (46.1%)
1
231 (36.3%)
2
72 (11.3%)
3
27 (4.2%)
4
13 (2.0%)
ALBI: albumin-bilirubin; AFP: alpha-fetoprotein; CSS: cirrhotic severity scoring; BCLC: Barcelona Clinical Liver Cancer; CLIP: Cancer of the Liver Italian Program.